New study aims to end HIV in latinx men with One-Stop PrEP shops

NCT ID NCT06406049

Recruiting now Prevention Sponsor: University of Miami Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a program to help Latinx men lower their HIV risk by combining easy access to PrEP medication, social support from friends, and a national pharmacy chain. Researchers will enroll 624 men aged 18-54 and track how many start and stick with PrEP. The goal is to create a simple, community-friendly model that could be used in other cities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pre-Exposure Prophylaxis (PrEP) medication
What this could lead to: If successful, this model could make HIV prevention easier and more accessible for Latinx men, reducing new infections in this community.
What could go wrong: This is a behavioral and service-delivery study, not a drug trial. Success depends on participants actually using PrEP, and results may not apply to other groups or regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

University of Miami
RECRUITING

Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.